Merrimack Pharmaceuticals Inc (MACK)
14.72
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
14.73
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Cash from Operations (TTM): -1.522M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.522M |
| September 30, 2023 | -1.412M |
| June 30, 2023 | -1.473M |
| March 31, 2023 | -1.744M |
| December 31, 2022 | -1.742M |
| September 30, 2022 | -1.912M |
| June 30, 2022 | -2.093M |
| March 31, 2022 | -0.135M |
| December 31, 2021 | -0.218M |
| September 30, 2021 | -1.639M |
| June 30, 2021 | -1.059M |
| March 31, 2021 | -4.057M |
| December 31, 2020 | -4.625M |
| September 30, 2020 | -5.489M |
| June 30, 2020 | -8.827M |
| March 31, 2020 | -18.72M |
| December 31, 2019 | -31.37M |
| September 30, 2019 | -47.62M |
| June 30, 2019 | -57.53M |
| March 31, 2019 | -61.90M |
| December 31, 2018 | -65.59M |
| September 30, 2018 | -71.49M |
| June 30, 2018 | -84.01M |
| March 31, 2018 | -132.99M |
| December 31, 2017 | -125.81M |
| Date | Value |
|---|---|
| September 30, 2017 | -131.92M |
| June 30, 2017 | -141.20M |
| March 31, 2017 | -126.87M |
| December 31, 2016 | -170.24M |
| September 30, 2016 | -142.65M |
| June 30, 2016 | -150.12M |
| March 31, 2016 | -123.80M |
| December 31, 2015 | -105.36M |
| September 30, 2015 | -133.73M |
| June 30, 2015 | -30.24M |
| March 31, 2015 | -38.50M |
| December 31, 2014 | -34.81M |
| September 30, 2014 | -30.55M |
| June 30, 2014 | -113.96M |
| March 31, 2014 | -105.37M |
| December 31, 2013 | -95.18M |
| September 30, 2013 | -87.18M |
| June 30, 2013 | -84.80M |
| March 31, 2013 | -81.61M |
| December 31, 2012 | -79.82M |
| September 30, 2012 | -66.84M |
| June 30, 2012 | -62.91M |
| March 31, 2012 | -62.28M |
| December 31, 2011 | -52.82M |
| September 30, 2011 | -52.34M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-57.53M
Minimum
Jun 2019
-0.135M
Maximum
Mar 2022
-10.17M
Average
-1.912M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |